Cardiac glycosides display selective efficacy for STK11 mutant lung cancer-Reference-Cited by-同舟云学术

Cardiac glycosides display selective efficacy for STK11 mutant lung cancer

Published:2016-07 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Kim Nayoung,Yim Hwa Young,He Ningning,Lee Cheol-Jung,Kim Ju Hyun,Choi Jin-Sung,Lee Hye Suk,Kim Somin,Jeong Euna,Song Mee,Jeon Sang-Min,Kim Woo-Young,Mills Gordon B.,Cho Yong-Yeon,Yoon Sukjoon

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep29721.pdf

Reference38 articles.

1. Shackelford, D. B. et al. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. Cancer Cell 23, 143–158 (2013).

2. Ji, H. et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 448, 807–810 (2007).

3. He, N. et al. Integrated analysis of transcriptomes of cancer cell lines and patient samples reveals STK11/LKB1-driven regulation of cAMP phosphodiesterase-4D. Mol Cancer Ther. 13, 2463–2473 (2014).

4. Reinhold, W. C. et al. CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res. 72, 3499–3511 (2012).

5. Shoemaker, R. H. The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 6, 813–823 (2006).

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of HSF1 Activity Inhibitor of the Cardenolide Group (CL-43) on Tumor and Nontransformed Cells;Cell and Tissue Biology;2024-08

2. SLAYER: Synthetic Lethality Analysis for Enhanced Targeted Therapy Implicates AhR inhibitor as a Target in RB1-Mutant Bladder Tumors;2024-05-04

3. Hypomethylation of ATP1A1 Is Associated with Poor Prognosis and Cancer Progression in Triple-Negative Breast Cancer;Cancers;2024-04-25

4. Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia;Annals of Hematology;2024-04-17

5. Effect of the HSF1 inhibitor Cl-43 on tumors and non-transformed cells;Цитология;2024-03-15